1310 related articles for article (PubMed ID: 27068264)
1. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
2. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
4. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
5. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
6. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
Cohen SJ; Cohen IR; Nussbaum G
J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
[TBL] [Abstract][Full Text] [Related]
7. Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent.
Lalor SJ; Segal BM
Eur J Immunol; 2013 Nov; 43(11):2866-74. PubMed ID: 23873018
[TBL] [Abstract][Full Text] [Related]
8. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Mangalam AK; Rattan R; Suhail H; Singh J; Hoda MN; Deshpande M; Fulzele S; Denic A; Shridhar V; Kumar A; Viollet B; Rodriguez M; Giri S
J Immunol; 2016 Aug; 197(3):747-60. PubMed ID: 27354217
[TBL] [Abstract][Full Text] [Related]
9. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
Lyons JA; Ramsbottom MJ; Cross AH
Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
[TBL] [Abstract][Full Text] [Related]
10. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
11. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system.
Müller M; Carter SL; Hofer MJ; Manders P; Getts DR; Getts MT; Dreykluft A; Lu B; Gerard C; King NJ; Campbell IL
J Immunol; 2007 Sep; 179(5):2774-86. PubMed ID: 17709491
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
16. CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease.
Sporici R; Issekutz TB
Eur J Immunol; 2010 Oct; 40(10):2751-61. PubMed ID: 21038468
[TBL] [Abstract][Full Text] [Related]
17. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
18. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
19. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
20. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]